Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Payton

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Virology|September 5, 2009
Analysis of potato virus X replicase and TGBp3 subcellular locationsDevinka Bamunusinghe, Cynthia L Hemenway, Richard S Nelson, et al.
Allergy|February 6, 2013
Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitisA Straumann, S Hoesli, Ch Bussmann, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 19, 2011
A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthmaN Barnes, I Pavord, A Chuchalin, et al.
Anaesthesia|September 16, 2022
Ease and comfort of pre-oxygenation with high-flow nasal oxygen cannulae vs. facemask: a randomised controlled trialA F Merry, H van Waart, S J Allen, et al.
Journal of Molecular Neuroscience : MN|September 6, 2002
Alzheimer's disease drug discovery targeted to the APP mRNA 5'untranslated regionJack T Rogers, Jeffrey D Randall, Paul S Eder, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Virology|September 5, 2009
Analysis of potato virus X replicase and TGBp3 subcellular locationsDevinka Bamunusinghe, Cynthia L Hemenway, Richard S Nelson, et al.
Allergy|February 6, 2013
Anti-eosinophil activity and clinical efficacy of the CRTH2 antagonist OC000459 in eosinophilic esophagitisA Straumann, S Hoesli, Ch Bussmann, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 19, 2011
A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthmaN Barnes, I Pavord, A Chuchalin, et al.
Anaesthesia|September 16, 2022
Ease and comfort of pre-oxygenation with high-flow nasal oxygen cannulae vs. facemask: a randomised controlled trialA F Merry, H van Waart, S J Allen, et al.
Journal of Molecular Neuroscience : MN|September 6, 2002
Alzheimer's disease drug discovery targeted to the APP mRNA 5'untranslated regionJack T Rogers, Jeffrey D Randall, Paul S Eder, et al.
Pageof 7